Ensuring Safety of COVID-19 Vaccines: Q&A with Robert Chen

December 12, 2020

Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coalition for Epidemic Preparedness Innovations (CEPI). To view the article click here.

More News

Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

June 2, 2025

Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine Congress

May 27, 2025

Lessons Learned from Vaccine Safety Surveillance Efforts

September 3, 2024

Dr. Punnee Pitisuttithum: Engaging community in active vaccine safety surveillance

July 31, 2024

Request for Review: Vaccine Safety Template – IDT Bio Manuscript

July 22, 2024

Request for Review: Vaccine Safety Template for Clover COVID-19 recombinant protein vaccine

July 2, 2024

More NEWS

June 2, 2025June 2, 2025

Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

Brighton Collaboration Releases New Template for Evaluating VSV-Based Lassa Fever Vaccines The Brighton Collaboration is proud to...

May 27, 2025May 27, 2025

Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine Congress

This April, global leaders in immunization, public health, and biotechnology convened in Washington, D.C. for the 2025 World Vacci...

September 3, 2024

Lessons Learned from Vaccine Safety Surveillance Efforts

Much has been learned about the need for vaccine safety surveillance through COVAX and other recent collaborative efforts. Here, w...

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

© Brighton Collaboration 2023. All rights reserved.